In its selection committee’s first round, the Rocky Mountain Life Science Investor Conference (RMLIC) has chosen 17 of thirty regional companies to showcase their technologies on Thursday, September 17th at the Ritz Carlton in Denver. The announcement is made by John Collar, President & CEO of the Colorado Bioscience Association (CBSA), whose organization is co-hosting the inaugural event with the Arizona BioIndustry Organization (AZBio), along with regional industry partners in Montana, Utah, and New Mexico.Companies selected in first-round vetting for the RMLIC include:
* Apoplogic - Aurora, CO
* BioAmps - Aurora, CO
* BioDesix - Broomfield, CO
* BiOptix - Boulder, CO
* Coherex – Salt Lake City, UT
* GlobeImmune - Louisville, CO
* High Throughput Genomics - Tucson, AZ
* Inviragen - Fort Collins, CO
* Kinetic Muscles - Tempe, AZ
* Lineagen - Salt Lake City, UT
* Medivance - Louisville, CO
* miRagen - Boulder, CO
* Myocept -Lafayette, CO
* Regenesis - Scottsdale, AZ
* ThermImage - Salt Lake City, UT
* ValvExchange - Aurora, CO
* Vital Access - Salt Lake City, UT
No comments:
Post a Comment